HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, N
Right arrow Articles by Hampton, J R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, N
Right arrow Articles by Hampton, J R
Heart 1999;81:598-602 ( June )

Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis

N Browna, M Melvillea, D Graya, T Youngb, A M Skeneb, R G Wilcoxa, J R Hamptona

a Division of Cardiovascular Medicine, University Hospital, Nottingham NG7 2UH, UK, b British Heart Foundation Cardiovascular Statistics Unit, University of Nottingham, Nottingham, UK

Correspondence to: Dr Brown.

Accepted for publication 29 January 1999

OBJECTIVE---To assess the medium to long term outcome of patients ineligible for thrombolysis compared to those enrolled in a clinical trial of thrombolysis and patients receiving non-trial thrombolysis.
DESIGN---Cohort study based on the Nottingham heart attack register.
SETTING---Two district general hospitals serving a defined urban/rural population.
SUBJECTS---All patients admitted with a confirmed acute myocardial infarction during 1992 categorised as either participants of a thrombolytic trial (group A, n = 140), receiving non-trial thrombolysis (group B, n = 329), or deemed ineligible for lytic treatment (group C, n = 431).
MAIN OUTCOME MEASURES---Background characteristics, inhospital treatment, patterns of follow up, referrals to cardiologists, revascularisation rates, and short and long term survival.
RESULTS---Clinical trial recruits were younger by almost 10 years, were less likely to have a previous history of myocardial infarction, and more likely to be in Killip class 1 on admission than those ineligible for thrombolysis. Cardiology follow up was mandatory for all surviving trial participants but 22% of patients in group B and 31% of patients in group C received no follow up, and during four years less than 50% ever saw a cardiologist. Revascularisation was performed in 17.2% of patients in group A, 13.6% of patients in group B, and 7.5% of patients in group C. Cumulative mortality at a median of four years was 24.3% in group A, 36.8% in B, and 59.6% in group C. Adjusting for age, sex, previous myocardial infarction, type of infarction, and Killip class in a logistic regression model the odds ratios (OR) of death at four years for groups B and C were 1.60 (95% confidence intervals (CI) 0.97 to 2.63, p = 0.065) and 2.64 (95% CI 1.61 to 4.32, p < 0.001), respectively, when compared to group A (OR 1).
CONCLUSIONS---Patients enrolled into thrombolytic trials are at low risk. Patients deemed ineligible for thrombolysis are high risk, receive less surveillance, are less likely to be revascularised or receive trial proven treatments, have a poor long term outcome not entirely explained by increased age or severity of infarction, and deserve further evaluation.


Keywords: myocardial infarction; thrombolysis; clinical trials

© 1999 by Heart


This article has been cited by other articles:


Home page
 CirculationHome page
B. K. Nallamothu, R. A. Hayward, and E. R. Bates
Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies
Circulation, September 16, 2008; 118(12): 1294 - 1303.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
P. G. Steg, J. Lopez-Sendon, E. Lopez de Sa, S. G. Goodman, J. M. Gore, F. A. Anderson Jr, D. Himbert, J. Allegrone, F. Van de Werf, and for the GRACE Investigators
External Validity of Clinical Trials in Acute Myocardial Infarction
Arch Intern Med, January 8, 2007; 167(1): 68 - 73.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. D. Roth-Cline
Clinical Trials in the Wake of Vioxx: Requiring Statistically Extreme Evidence of Benefit to Ensure the Safety of New Drugs
Circulation, May 9, 2006; 113(18): 2253 - 2259.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
C. J. Terkelsen, J. F. Lassen, B. L. Norgaard, J. C. Gerdes, T. Jensen, L. B.-H. Gotzsche, T. T. Nielsen, and H. R. Andersen
Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
Eur. Heart J., January 1, 2005; 26(1): 18 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Kastrati, J. Mehilli, S. Nekolla, H. Bollwein, S. Martinoff, J. Pache, H. Schuhlen, M. Seyfarth, M. Gawaz, F.-J. Neumann, et al.
A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 734 - 741.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J. HAMPTON
Immediate angioplasty for the National Health Service?
Heart, September 1, 2001; 86(3): 241 - 242.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S.T. Higano and B.J. Gersh
Coronary angiography and outcome following acute myocardial infarction
Eur. Heart J., May 1, 2000; 21(9): 707 - 709.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Cardiovascular Society